Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Devoogdt

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Cancers|July 26, 2019
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast CancerChristopher Montemagno, Laurent Dumas, Pierre Cavaillès, et al.
Theranostics|May 22, 2024
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid LeukemiaNiels Vandewalle, Hatice Satilmis, Emma Verheye, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β<sub>2</sub> Adrenergic Receptor LigandsCharlotte Martin, Samuel L C Moors, Mia Danielsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor MicroenvironmentThomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, et al.
Theranostics|November 1, 2023
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8<sup>+</sup> T cell and iNKT cell activating mRNA vaccineThomas Ertveldt, Sofie Meulewaeter, Yannick De Vlaeminck, et al.
International Review of Cell and Molecular Biology|July 1, 2022
Emerging applications of nanobodies in cancer therapyRobin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, et al.
Scientific Reports|November 11, 2017
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cellsAlexander Balhuizen, Sam Massa, Iris Mathijs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsMatthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Vicky Caveliers, Catarina Xavier, et al.
European Journal of Immunology|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal CavityEls Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Cancers|July 26, 2019
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast CancerChristopher Montemagno, Laurent Dumas, Pierre Cavaillès, et al.
Theranostics|May 22, 2024
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid LeukemiaNiels Vandewalle, Hatice Satilmis, Emma Verheye, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β<sub>2</sub> Adrenergic Receptor LigandsCharlotte Martin, Samuel L C Moors, Mia Danielsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor MicroenvironmentThomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, et al.
Theranostics|November 1, 2023
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8<sup>+</sup> T cell and iNKT cell activating mRNA vaccineThomas Ertveldt, Sofie Meulewaeter, Yannick De Vlaeminck, et al.
International Review of Cell and Molecular Biology|July 1, 2022
Emerging applications of nanobodies in cancer therapyRobin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, et al.
Scientific Reports|November 11, 2017
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cellsAlexander Balhuizen, Sam Massa, Iris Mathijs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsMatthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Vicky Caveliers, Catarina Xavier, et al.
European Journal of Immunology|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal CavityEls Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, et al.
Pageof 16